Pityriasis amiantacea: A distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy

Clinical and Experimental Dermatology

Volumn 37, Issue 6, 2012, Pages 639-641

  Ettler, J ^a   Wetter, D A ^a   Pittelkow, M R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; INFLIXIMAB; KERATOLYTIC AGENT; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; CROHN DISEASE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; HUMAN; MALE; PITYRIASIS; PITYRIASIS AMIANTACEA; PRIORITY JOURNAL; PSORIASIS; STAPHYLOCOCCUS AUREUS;

ANTI-INFLAMMATORY AGENTS; CROHN DISEASE; DRUG ERUPTIONS; HUMANS; MALE; PITYRIASIS; SCALP DERMATOSES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84864129801     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04286.x     Document Type: Article

References (10)

1. Langtry JA, Ive FA,. Pityriasis amiantacea, an unrecognized cause of scarring alopecia, described in four patients. Acta Derm Venereol 1991; 71: 352-3.
2. Abdel-Hamid IA, Agha SA, Moustafa YM, El-Labban AM,. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol 2003; 42: 260-4.
3. Knight AG,. Pityriasis amiantacea: a clinical and histopathological investigation. Clin Exp Dermatol 1977; 2: 137-43.
4. Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR,. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998-2010. J Am Acad Dermatol 2011; doi: 10.1016/j.jaad.2011.05.038.
5. Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008; 9: 1-14 (erratum in Am J Clin Dermatol 2008; 9: 347).
6. Vlassova N, Han A, Zenilman JM, et al. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol 2011; 165: 751-9.
7. Smith K, Perez A, Ramage G, et al. Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J Med Microbiol 2008; 57: 1018-23.
8. de Gannes GC, Ghoreishi M, Pope J, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007; 143: 223-31.
9. Viguier M, Guigue P, Pages C, et al. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations. Ann Intern Med 2010; 153: 66-7.
10. Sfikakis PP, Kollias G,. Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 2003; 15: 380-6.